Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo
- 1 July 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 90 (3) , 721-724
- https://doi.org/10.1111/j.1365-2141.1995.tb05609.x
Abstract
Summary. We studied the bone resorption (BR) in 82 patients with overt plasmacytomas (PCT) by histomorpho-metry. All the solitary PCT and 90% of overt PCT in complete remission lacked excessive BR. In contrast, 73% of the 68 patients with active overt PCT had an excessive BR. This excessive BR was highly related to the presence of tumour cells within the bone sample. Indeed, 92% of patients with active PCT and tumour cells within the biopsy had an excessive BR. On the other hand, 70% of patients with active PCT but lacking tumour cells within the biopsy had normal BR.Keywords
This publication has 11 references indexed in Scilit:
- Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow culturesBlood, 1994
- Perspectives: Interleukin-6: An osteotropic factor?Journal of Bone and Mineral Research, 1992
- 'Role of bone marrow stromal cells in the growth of human multiple myelomaBlood, 1991
- Osteoblast stimulation in multiple myeloma lacking lytic bone lesionsBritish Journal of Haematology, 1990
- Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease.Journal of Clinical Oncology, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Importance of quantitative histology of bone changes in monoclonal gammopathyBritish Journal of Cancer, 1986
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- The many facets of multiple myelomaSeminars in Roentgenology, 1974